A plug-and-play approach to antibody-based therapeutics via a chemoselective dual click strategy
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A plug-and-play approach to antibody-based therapeutics via a chemoselective dual click strategy
Authors
Keywords
-
Journal
Nature Communications
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-03-31
DOI
10.1038/ncomms7645
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A mild TCEP-based para-azidobenzyl cleavage strategy to transform reversible cysteine thiol labelling reagents into irreversible conjugates
- (2015) Antoine Maruani et al. CHEMICAL COMMUNICATIONS
- Macromolecular Bipill of Gemcitabine and Methotrexate Facilitates Tumor-Specific Dual Drug Therapy with Higher Benefit-to-Risk Ratio
- (2014) Manasmita Das et al. BIOCONJUGATE CHEMISTRY
- Bridging Disulfides for Stable and Defined Antibody Drug Conjugates
- (2014) George Badescu et al. BIOCONJUGATE CHEMISTRY
- Production of Site-Specific Antibody–Drug Conjugates Using Optimized Non-Natural Amino Acids in a Cell-Free Expression System
- (2014) Erik S. Zimmerman et al. BIOCONJUGATE CHEMISTRY
- A prospective antibacterial for drug-resistant pathogens: a dual warhead amphiphile designed to track interactions and kill pathogenic bacteria by membrane damage and cellular DNA cleavage
- (2014) Durairaj Thiyagarajan et al. CHEMICAL COMMUNICATIONS
- Next generation maleimides enable the controlled assembly of antibody–drug conjugates via native disulfide bond bridging
- (2014) Felix F. Schumacher et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Emerging classes of armed antibody therapeutics against cancer
- (2014) Christian Hess et al. MedChemComm
- Theranostics in the Growing Field of Personalized Medicine: An Analytical Chemistry Perspective
- (2013) Niall Crawley et al. ANALYTICAL CHEMISTRY
- Combating Multidrug-Resistant Bacteria: Current Strategies for the Discovery of Novel Antibacterials
- (2013) Kieron M. G. O'Connell et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Acid-cleavable thiomaleamic acid linker for homogeneous antibody–drug conjugation
- (2013) Lourdes Castañeda et al. CHEMICAL COMMUNICATIONS
- Maturing antibody–drug conjugate pipeline hits 30
- (2013) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Homogeneous antibody fragment conjugation by disulfide bridging introduces ‘spinostics’
- (2013) Felix F. Schumacher et al. Scientific Reports
- Antibody-Drug Conjugates for the Treatment of Cancer
- (2012) John A. Flygare et al. Chemical Biology & Drug Design
- Antibody–drug conjugates – a perfect synergy
- (2012) John R Adair et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
- (2012) Sunil Verma et al. NEW ENGLAND JOURNAL OF MEDICINE
- In Situ Maleimide Bridging of Disulfides and a New Approach to Protein PEGylation
- (2011) Felix F. Schumacher et al. BIOCONJUGATE CHEMISTRY
- Tunable reagents for multi-functional bioconjugation: reversible or permanent chemical modification of proteins and peptides by control of maleimide hydrolysis
- (2011) Chris P. Ryan et al. CHEMICAL COMMUNICATIONS
- Bromopyridazinedione-mediated protein and peptide bioconjugation
- (2011) Vijay Chudasama et al. CHEMICAL COMMUNICATIONS
- Challenges of Antibacterial Discovery
- (2011) L. L. Silver CLINICAL MICROBIOLOGY REVIEWS
- Multimodal radio- (PET/SPECT) and fluorescence imaging agents based on metallo-radioisotopes: current applications and prospects for development of new agents
- (2011) Flora L. Thorp-Greenwood et al. DALTON TRANSACTIONS
- Investigational antibody drug conjugates for solid tumors
- (2011) Puja Sapra et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
- (2010) J. R. Junutula et al. CLINICAL CANCER RESEARCH
- Antibody–drug conjugates: targeted drug delivery for cancer
- (2010) Stephen C Alley et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Protein Modification, Bioconjugation, and Disulfide Bridging Using Bromomaleimides
- (2010) Mark E. B. Smith et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Antibody−Drug Conjugates: Linking Cytotoxic Payloads to Monoclonal Antibodies
- (2009) Laurent Ducry et al. BIOCONJUGATE CHEMISTRY
- A modeling analysis of the effects of molecular size and binding affinity on tumor targeting
- (2009) M. M. Schmidt et al. MOLECULAR CANCER THERAPEUTICS
- Antibody tumor penetration: Transport opposed by systemic and antigen-mediated clearance
- (2008) Greg M. Thurber et al. ADVANCED DRUG DELIVERY REVIEWS
- The Pharmacology of PEGylation: Balancing PD with PK to Generate Novel Therapeutics
- (2008) C.Simone Fishburn JOURNAL OF PHARMACEUTICAL SCIENCES
- Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
- (2008) Jagath R Junutula et al. NATURE BIOTECHNOLOGY
- Disulfide bridge based PEGylation of proteins
- (2007) Steve Brocchini et al. ADVANCED DRUG DELIVERY REVIEWS
- Using a synthetic body fluid (SBF) solution of 27 mM HCO3− to make bone substitutes more osteointegrative
- (2007) Sahil Jalota et al. Materials Science & Engineering C-Materials for Biological Applications
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search